Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Genpact (G) shares
Learn how to easily invest in Genpact shares.
Genpact is an information technology services business based in the US. Genpact stocks (G.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $45.82 – a decrease of 4.83% over the previous week. Genpact employs 105,400 staff and has a trailing 12-month revenue of around $3.9 billion.
How to buy shares in Genpact
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – G – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Genpact?
- Has coronavirus impacted Genpact shares?
- Genpact shares summary
- Compare share dealing platforms
- Is Genpact stock a buy or sell?
- Genpact performance over time
- Are Genpact shares over-valued?
- Genpact's financials
- How volatile are Genpact shares?
- Does Genpact pay a dividend?
- Other common questions
Genpact stock price (NYSE:G)Use our graph to track the performance of G stocks over time.
Genpact shares at a glance
|Latest market close||$48.46|
|52-week range||$38.01 - $54.03|
|50-day moving average||$51.19|
|200-day moving average||$48.82|
|Wall St. target price||$52.73|
|Dividend yield||$0.42 (0.86%)|
|Earnings per share (TTM)||$1.92|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Genpact stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Genpact price performance over time
|1 week (2022-01-19)||-4.83%|
|1 month (2021-12-23)||-7.45%|
|3 months (2021-10-26)||-4.68%|
|6 months (2021-07-26)||-2.12%|
|1 year (2021-01-26)||19.10%|
|2 years (2020-01-24)||9.37%|
|3 years (2019-01-25)||65.00%|
|5 years (2017-01-26)||98.36%|
Is Genpact under- or over-valued?
Valuing Genpact stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genpact's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genpact's P/E ratio
Genpact's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Genpact shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Genpact's PEG ratio
Genpact's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Genpact's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Genpact's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $694.2 million.
The EBITDA is a measure of a Genpact's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.9 billion|
|Operating margin TTM||13.69%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||6.77%|
|Return on equity TTM||19.91%|
|Market capitalisation||$9.1 billion|
TTM: trailing 12 months
Genpact share dividends
Dividend payout ratio: 17.77% of net profits
Recently Genpact has paid out, on average, around 17.77% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.86% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genpact shareholders could enjoy a 0.86% return on their shares, in the form of dividend payments. In Genpact's case, that would currently equate to about $0.42 per share.
While Genpact's payout ratio might seem low, this can signify that Genpact is investing more in its future growth.
Genpact's most recent dividend payout was on 21 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 December 2021 (the "ex-dividend date").
Genpact share price volatility
Over the last 12 months, Genpact's shares have ranged in value from as little as $38.0103 up to $54.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genpact's is 1.4105. This would suggest that Genpact's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company's finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. It also provides supply chain design, planning, inventory optimization, transportation and logistics management, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, master data management, and other procurement and supply chain advisory services; and sales and commercial services in the lead-to-quote, quote-to-order, and customer service areas. In addition, the company offers IT services, which include end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. It serves banking, capital market, insurance, consumer goods, retail, life science, healthcare, high tech, and manufacturing and service industries. Genpact Limited was founded in 1997 and is based in Hamilton, Bermuda.
Genpact in the news
What's in Store for Waste Management (WM) in Q4 Earnings?
What Awaits Automatic Data Processing (ADP) in Q2 Earnings?
MHRA Expands Relationship with Commonwealth Informatics to Transform Drug Safety
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.